Remedent, Inc. (REMI)
USD 0.06
(0.0%)
USD 0.06
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -274.44 Thousand USD | 81.64% |
| 2023 | -1.49 Million USD | -481.24% |
| 2022 | -257.18 Thousand USD | -57.68% |
| 2021 | -163.1 Thousand USD | 80.91% |
| 2020 | -854.26 Thousand USD | -140.13% |
| 2019 | 2.12 Million USD | 3999.54% |
| 2018 | -54.59 Thousand USD | -106.47% |
| 2017 | 844.37 Thousand USD | 425.1% |
| 2016 | 160.8 Thousand USD | 52.91% |
| 2015 | 105.15 Thousand USD | -79.95% |
| 2014 | 524.5 Thousand USD | 153.42% |
| 2013 | -981.93 Thousand USD | -300.2% |
| 2012 | 490.48 Thousand USD | 131.7% |
| 2011 | -1.54 Million USD | 34.16% |
| 2010 | -2.34 Million USD | 20.42% |
| 2009 | -2.95 Million USD | 5.22% |
| 2008 | -3.11 Million USD | -108.25% |
| 2007 | -1.49 Million USD | 61.51% |
| 2006 | -3.88 Million USD | -3658.46% |
| 2005 | -103.42 Thousand USD | -225.34% |
| 2004 | -31.79 Thousand USD | 96.84% |
| 2003 | -1 Million USD | 48.75% |
| 2002 | -1.96 Million USD | -154.43% |
| 2001 | -771.85 Thousand USD | 14.49% |
| 2000 | -902.69 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q4 | -219.34 Thousand USD | -708.62% |
| 2024 FY | -274.44 Thousand USD | 81.64% |
| 2024 Q1 | -61.63 Thousand USD | 87.64% |
| 2024 Q2 | -29.5 Thousand USD | 52.13% |
| 2024 Q3 | 36.03 Thousand USD | 222.13% |
| 2023 Q4 | -498.49 Thousand USD | -86.41% |
| 2023 FY | -1.49 Million USD | -481.24% |
| 2023 Q3 | -267.42 Thousand USD | 23.54% |
| 2023 Q2 | -349.76 Thousand USD | 7.75% |
| 2023 Q1 | -379.14 Thousand USD | 0.0% |
| 2022 FY | -257.18 Thousand USD | -57.68% |
| 2021 FY | -163.1 Thousand USD | 80.91% |
| 2021 Q2 | 61.34 Thousand USD | 2319.8% |
| 2021 Q3 | 94.45 Thousand USD | 53.98% |
| 2021 Q1 | 2535.00 USD | 100.71% |
| 2020 Q4 | -355.93 Thousand USD | -117.99% |
| 2020 Q3 | -163.28 Thousand USD | -2.31% |
| 2020 Q2 | -159.59 Thousand USD | 16.51% |
| 2020 Q1 | -191.14 Thousand USD | -107.49% |
| 2020 FY | -854.26 Thousand USD | -140.13% |
| 2019 Q2 | -76.15 Thousand USD | 52.03% |
| 2019 Q4 | 2.55 Million USD | 1458.95% |
| 2019 Q3 | -187.75 Thousand USD | -146.55% |
| 2019 FY | 2.12 Million USD | 3999.54% |
| 2019 Q1 | -158.76 Thousand USD | 27.47% |
| 2018 Q2 | 49.72 Thousand USD | -20.35% |
| 2018 Q3 | 52.13 Thousand USD | 4.85% |
| 2018 Q4 | -218.88 Thousand USD | -519.82% |
| 2018 Q1 | 62.43 Thousand USD | -89.62% |
| 2018 FY | -54.59 Thousand USD | -106.47% |
| 2017 FY | 844.37 Thousand USD | 425.1% |
| 2017 Q2 | 29.49 Thousand USD | -70.92% |
| 2017 Q3 | 111.87 Thousand USD | 279.33% |
| 2017 Q4 | 601.58 Thousand USD | 437.73% |
| 2017 Q1 | 101.41 Thousand USD | 188.85% |
| 2016 FY | 160.8 Thousand USD | 52.91% |
| 2016 Q1 | 196.6 Thousand USD | 552.15% |
| 2016 Q4 | -114.14 Thousand USD | -582.42% |
| 2016 Q2 | 54.67 Thousand USD | -72.19% |
| 2016 Q3 | 23.66 Thousand USD | -56.73% |
| 2015 Q2 | 85.19 Thousand USD | 47.81% |
| 2015 Q4 | -43.48 Thousand USD | -848.93% |
| 2015 Q3 | 5806.00 USD | -93.19% |
| 2015 Q1 | 57.64 Thousand USD | -84.5% |
| 2015 FY | 105.15 Thousand USD | -79.95% |
| 2014 Q2 | -11.15 Thousand USD | -121.1% |
| 2014 Q3 | 110.94 Thousand USD | 1094.67% |
| 2014 FY | 524.5 Thousand USD | 153.42% |
| 2014 Q1 | 52.85 Thousand USD | -87.49% |
| 2014 Q4 | 371.85 Thousand USD | 235.17% |
| 2013 Q3 | -435.51 Thousand USD | -389.0% |
| 2013 FY | -981.93 Thousand USD | -300.2% |
| 2013 Q4 | 422.62 Thousand USD | 197.04% |
| 2013 Q2 | -89.06 Thousand USD | 89.88% |
| 2013 Q1 | -879.98 Thousand USD | -158.14% |
| 2012 Q2 | -424.31 Thousand USD | -26.79% |
| 2012 Q3 | -264.21 Thousand USD | 37.73% |
| 2012 Q4 | 1.51 Million USD | 672.91% |
| 2012 FY | 490.48 Thousand USD | 131.7% |
| 2012 Q1 | -334.67 Thousand USD | 83.89% |
| 2011 Q3 | 16.74 Thousand USD | -91.68% |
| 2011 FY | -1.54 Million USD | 34.16% |
| 2011 Q1 | 312.15 Thousand USD | 348.57% |
| 2011 Q2 | 201.22 Thousand USD | -35.54% |
| 2011 Q4 | -2.07 Million USD | -12508.64% |
| 2010 Q2 | -838.78 Thousand USD | -52.66% |
| 2010 Q4 | -125.58 Thousand USD | 84.98% |
| 2010 FY | -2.34 Million USD | 20.42% |
| 2010 Q1 | -549.43 Thousand USD | 49.12% |
| 2010 Q3 | -836.12 Thousand USD | 0.32% |
| 2009 Q3 | 2.48 Million USD | 153.01% |
| 2009 FY | -2.95 Million USD | 5.22% |
| 2009 Q4 | -1.07 Million USD | -143.46% |
| 2009 Q1 | 330.5 Thousand USD | 153.04% |
| 2009 Q2 | -4.68 Million USD | -1518.16% |
| 2008 Q3 | -1.09 Million USD | -9.16% |
| 2008 Q1 | -390.95 Thousand USD | -538.77% |
| 2008 FY | -3.11 Million USD | -108.25% |
| 2008 Q4 | -623.06 Thousand USD | 43.19% |
| 2008 Q2 | -1 Million USD | -157.0% |
| 2007 Q4 | 89.1 Thousand USD | 113.76% |
| 2007 FY | -1.49 Million USD | 61.51% |
| 2007 Q3 | -647.56 Thousand USD | -561.74% |
| 2007 Q2 | -97.85 Thousand USD | 88.35% |
| 2007 Q1 | -839.73 Thousand USD | 8.89% |
| 2006 Q4 | -921.65 Thousand USD | 45.86% |
| 2006 FY | -3.88 Million USD | -3658.46% |
| 2006 Q1 | -1.01 Million USD | -817.47% |
| 2006 Q2 | -250.84 Thousand USD | 75.22% |
| 2006 Q3 | -1.7 Million USD | -578.68% |
| 2005 Q3 | -80.24 Thousand USD | -324.27% |
| 2005 FY | -103.42 Thousand USD | -225.34% |
| 2005 Q2 | 35.77 Thousand USD | -30.37% |
| 2005 Q1 | 51.38 Thousand USD | 115.59% |
| 2005 Q4 | -110.34 Thousand USD | -37.51% |
| 2004 Q4 | -329.49 Thousand USD | -189.78% |
| 2004 Q1 | -2186.00 USD | 99.54% |
| 2004 Q2 | -67.12 Thousand USD | -2970.86% |
| 2004 FY | -31.79 Thousand USD | 96.84% |
| 2004 Q3 | 367.01 Thousand USD | 646.73% |
| 2003 Q1 | -159.54 Thousand USD | 77.39% |
| 2003 FY | -1 Million USD | 48.75% |
| 2003 Q4 | -474.97 Thousand USD | -266.68% |
| 2003 Q3 | -129.53 Thousand USD | 46.54% |
| 2003 Q2 | -242.31 Thousand USD | -51.88% |
| 2002 Q4 | -705.71 Thousand USD | -54.04% |
| 2002 FY | -1.96 Million USD | -154.43% |
| 2002 Q1 | -363.01 Thousand USD | -48.66% |
| 2002 Q2 | -436.93 Thousand USD | -20.36% |
| 2002 Q3 | -458.13 Thousand USD | -4.85% |
| 2001 FY | -771.85 Thousand USD | 14.49% |
| 2001 Q2 | -180.53 Thousand USD | -9.99% |
| 2001 Q3 | -157 Thousand USD | 13.03% |
| 2001 Q4 | -244.19 Thousand USD | -55.54% |
| 2001 Q1 | -164.13 Thousand USD | 0.0% |
| 2000 FY | -902.69 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Medical Technologies Inc. | -926.89 Thousand USD | 70.391% |
| Ansell Limited | 76.5 Million USD | 100.359% |
| Ansell Limited | 76.5 Million USD | 100.359% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | 24.28 Million USD | 101.13% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -1.63 Million USD | 83.165% |
| Psykey, Inc. | -1.32 Million USD | 79.271% |
| ConvaTec Group Plc | 130.3 Million USD | 100.211% |
| ConvaTec Group Plc | 130.3 Million USD | 100.211% |
| Encision Inc. | -691.78 Thousand USD | 60.328% |
| Golden Valley Development, Inc | -141.81 Thousand USD | -93.529% |
| Hear AtLast Holdings, Inc. | -234.36 Thousand USD | -17.101% |
| Innovative MedTech Inc. | -7.93 Million USD | 96.543% |
| LifePoint, Inc. | -15.23 Million USD | 98.198% |
| Medite Cancer Diagnostics, Inc. | -6.81 Million USD | 95.971% |
| Paradigm Medical Industries, Inc. | -474 Thousand USD | 42.1% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Reflect Scientific, Inc. | -459.02 Thousand USD | 40.211% |
| SmileDirectClub, Inc. | -86.4 Million USD | 99.682% |
| Sector 10, Inc. | 7036.00 USD | 4000.597% |
| Shandong Weigao Group Medical Polymer Company Limited | 2 Billion USD | 100.014% |
| SheerVision, Inc. | -71.37 Thousand USD | -284.507% |
| United Health Products, Inc. | -2.62 Million USD | 89.538% |
| Vasamed, Inc. | -4.88 Million USD | 94.385% |
| Wearable Health Solutions, Inc. | -2.38 Million USD | 88.51% |
| Yubo International Biotech Limited | -1.2 Million USD | 77.22% |